On the surface, it may sometimes look like drug companies are doing good things with their money and trying to improve the society that consumes their products. Nestle, a candy company based in Switzerland, is partnering with a drug company to provide its food engineering expertise in a joint effort to make medicines taste good. […]
Tag: prices
Big Pharma Greed: Dirty Drug Patents
Moderna is a drug company that’s been very secretive about what product they’re developing. The startup claims to be working on a new class of drugs that manipulate antibodies into producing drugs via therapeutic proteins (Vardi, 2016). It wasn’t until Acuitas filed a lawsuit in British Columbia that Moderna revealed exactly what they’re working on. […]
With all of the settlements that Big Pharma has to pay, one might conclude that the industry is not stable enough to support itself; however, drug companies are experiencing growth and are commonly found on the Fortune 500 List (Law, 2006). According AlterNet, “Pharmaceutical companies have been hit with $14.8 billion in wrongdoing settlements in […]
Drug Prices: The Solution
If the system isn’t entertaining a solution to decrease drug costs, a solution can be implemented to decrease medical costs which will decrease prescription costs. Dr. Barbara McAneny, CEO of the New Mexico Cancer Center, has demonstrated that it’s possible to decrease costs while improving patient care. Appropriately prioritizing care via comprehensive triage and treatment […]
Drug Prices: Blame Regulation
Some argue that it was too much regulation, not too little regulation that has caused the FDA to reject competing drugs due to existing patents. In a sense, this is good so that pharmaceutical companies can recoup R&D costs to create new drugs. On the other hand, the patients need to be able to afford […]
Drug Prices: Blame the PBM
Some critics of industry prices think the high prices are due to pharmacy benefit managers (PBMs). PBMs are essentially the middleman between the pharmacy and the drug manufacturer. However, as Tim Wentworth, a CEO from Express Scripts states, “Drug makers set prices, and we [the PBM] exist to bring them down” (Weinberg & Langreth, 2017). […]
Looking back in time, it’s mind-boggling to think about how Big Pharma pricing became so far out of control. Insulin therapy, presently in mainstream high supply and demand, used to be a cutting-edge treatment that was difficult to create. The three person team that created a way to generate insulin recognized the need for this […]
Drug Prices: Epi-Pen
A very recent point of contention is the price of Epi-Pens® (Mylan). Epi-Pens® save the lives of people who experience anaphylactic shocks. Due to numerous petitions, Mylan claims that they dropped the price of the Epi-Pen®. But in reality, Mylan simply offered a $300 savings card to underinsured consumers (“The Other 98%”, 2017). Everyone else, […]
Drug Prices: Trends
The world’s most expensive drug, as of 2016, is Soliris® (Alexion Pharmaceuticals) being priced at $409,500 a year per patient. The disease that this drug treats only affects 8,000 Americans, but the drug maker generated $295 million in one year for that one drug (Herper, 2010). Turing Pharmaceuticals raised the price of an anti-infection drug […]